Reliable Biopharmaceutical Adds Jeff Jochims to Board of Directors
St. Louis, MO (PRWEB) April 18, 2016 -- Reliable Biopharmaceutical LLC, a cGMP manufacturer of active pharmaceutical and high purity ingredients, today announced the appointment of Jeff Jochims as an independent member of its newly reformed Board. “We’re excited to welcome Jeff to our Board and look forward to leveraging his global experience in the life sciences industry. Jeff brings a strong customer orientation and tremendous track record of growth and share gains that will be a great asset as we position our business to fill market demand for cGMP specialty chemicals around the world,” expressed David Feldker, President and CEO of Reliable.
Jeff brings to Reliable a long history in the life sciences industry, having spent 15 years as a senior executive with Thermo Fisher Scientific, including several years of very successful performance while President of the global Fisher Scientific channel. Jeff joins the Reliable Board as an independent member. John Hollenbach, Founder of Blue Diamond Capital and Reliable Executive Chairman, added, “I’ve known Jeff for many years and have worked with Jeff in several different capacities. We are very excited to complete the formation of our Board with Jeff’s addition.”
About Reliable Biopharmaceutical LLC
Reliable is an integrated developer and cGMP-certified manufacturer of Active Pharmaceutical Ingredients (APIs) and High Purity Ingredients (HPIs) for pharmaceutical and biologics production. It has established a strong position as a developer and manufacturer of complex generic injectable APIs. The company has a number of DMFs that have been accepted by Regulatory Agencies and has more in various stages of development. Reliable also manufactures critical raw materials used in biopharmaceutical drug production, including high purity sugars, biological buffers, reagents, and excipients.
James Wickenhauser, Reliable Biopharmaceutical, http://www.reliablebiopharm.com, +1 (314)561-4257, [email protected]
Share this article